Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Hemodynamic Monitoring Systems Companies

ID: MRFR/MED/5215-CR
200 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Hemodynamic monitoring involves the measurement and assessment of various cardiovascular parameters to evaluate the function of the cardiovascular system. Hemodynamic monitoring systems play a crucial role in critical care settings, assisting healthcare professionals in managing patients with cardiovascular instability.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Hemodynamic Monitoring Systems Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)4.30%
2025 Market SizeUSD 1.27 Billion
2035 Market SizeUSD 1.94 Billion
Key Players
Getinge AB
ICU Medical, Inc.
Baxter International
LiDCO Group plc
CNSystems Medizintechnik AG
Deltex Medical Group plc
Opportunities
  • Wearable and Patch-Based Hemodynamic Sensors
  • AI-Powered Predictive Dashboards and Software Monetization
  • Emerging-Market Hospital Infrastructure Build-Outs

Top Industry Leaders in the Hemodynamic Monitoring Systems Market

Hemodynamic Monitoring System Key Companies
 
Latest Hemodynamic Monitoring System Companies Update:

Edwards Lifesciences Corporation Received FDA approval for their Acorn Flex Plus Monitoring System in July 2023, featuring advanced hemodynamic parameters and simplified workflow for improved patient care.

Getinge AB Launched the SenTec™ Hemodynamic Monitoring System in November 2023, offering continuous and non-invasive monitoring of cardiac output and other vital signs.

Baxter International Introduced the ExactaMix Pro Automated Compounder in December 2022, enabling precise and efficient preparation of personalized cardiopulmonary bypass medications, improving hemodynamic stability during surgery.

LiDCO Group Partnered with a leading medical technology company in February 2024 to develop a next-generation minimally invasive hemodynamic monitoring device using bioimpedance spectroscopy.

Deltex Medical Announced the expansion of its production capacity for their CardioQ™ esophageal pressure monitoring system in January 2024, aiming to meet the growing demand for accurate hemodynamic monitoring in cardiac surgery.

List of Hemodynamic Monitoring System Key companies in the market
  • Edwards Lifesciences Corporation
  • Getinge AB
  • Baxter International Inc.
  • Drägerwerk AG & Co. KGaA
  • LiDCO Group
  • Osypka Medical GmbH
  • Deltex Medical
  • ICU Medical
  • CNSYSTEMS MEDIZINTECHNIK GMBH
  • NI Medical